7 research outputs found

    Safety of human MRI at static fields above the FDA 8T guideline: Sodium imaging at 9.4T does not affect vital signs or cognitive ability.

    No full text
    Purpose: To assess whether exposure to a 9.4T static magnetic field during sodium imaging at 105.92 MHz affects human vital signs and cognitive function. Materials and Methods: Measurements of human vital signs and cognitive ability made before and after exposure to a 9.4T MR scanner and a mock scanner with no magnetic field are compared using a protocol approved by the United States Food and Drug Administration. Results: Exposure to a 9.4T static magnetic field during sodium imaging did not result in a statistically significant change in the vital signs or cognitive ability of healthy normal volunteers. Conclusion: Vital sign and cognitive ability measurements made before and after sodium imaging at 9.4T suggest that performing human MRI at 105.92 MHz in a 9.4T static magnetic field does not pose a health risk

    Detection of Intracranial In-Stent Restenosis Using Quantitative Magnetic Resonance Angiography

    No full text
    BACKGROUND AND PURPOSE: In-stent restenosis (ISR) after angioplasty/stenting for intracranial stenosis has been reported in up to 25% to 30% of patients. Detection and monitoring of ISR relies primarily on serial catheter angiography, because noninvasive imaging methods are typically hampered by stent-related artifact. We examined the value of serial vessel flow measurements using quantitative magnetic resonance angiography (QMRA) in detection of ISR. Material and METHODS: Records of patients undergoing stenting for intracranial symptomatic stenosis >50% between 2005 and 2009 were retrospectively reviewed. Angiographic images were graded by a blinded neurointerventionalist for stenosis pretreatment, immediately after treatment, and during follow-up. Flow in the affected vessel measured by QMRA was recorded; > 25% reduction in flow was considered indicative of an adverse change. Clinical data regarding neurological outcome were also collected. RESULTS: Twenty-eight patients underwent stenting during the time interval studied. Of these, 12 patients (mean age, 55.5 years; 8 female) had contemporaneous angiography and QMRA and were analyzed. Median follow-up was 9 months. Six patients (50%) demonstrated angiographic restenosis 2 to 12 months after treatment; all had an analogous decrease in flow in the vessel of interest. Of 3 patients with more severe flow decrement (> 50%), 2 experienced stroke. None of the patients without angiographic ISR demonstrated a flow decrease on QMRA. CONCLUSIONS: In this preliminary series, flow decrease on QMRA is highly predictive of angiographic ISR. Additionally, the degree of flow decrement correlates with symptomatic ISR. QMRA may provide a useful noninvasive tool for serial monitoring after intracranial stenting
    corecore